These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33583641)

  • 1. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Grimm J; Vargo JA; Mavroidis P; Moiseenko V; Emami B; Jain S; Caudell JJ; Clump DA; Ling DC; Das S; Moros EG; Vinogradskiy Y; Xue J; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):147-159. PubMed ID: 33583641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of carotid blowout after reirradiation of the head and neck: a systematic review.
    McDonald MW; Moore MG; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1083-9. PubMed ID: 21549520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Sahgal A; Chang JH; Ma L; Marks LB; Milano MT; Medin P; Niemierko A; Soltys SG; Tomé WA; Wong CS; Yorke E; Grimm J; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):124-136. PubMed ID: 31606528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y
    Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
    Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
    Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
    Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dose-volume effects in the spinal cord.
    Kirkpatrick JP; van der Kogel AJ; Schultheiss TE
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S42-9. PubMed ID: 20171517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation myelopathy following stereotactic body radiation therapy for spine metastases.
    Ong WL; Wong S; Soliman H; Myrehaug S; Tseng CL; Detsky J; Husain Z; Maralani P; Ma L; Lo SS; Sahgal A
    J Neurooncol; 2022 Aug; 159(1):23-31. PubMed ID: 35737172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
    Ling DC; Vargo JA; Gebhardt BJ; Grimm RJ; Clump DA; Ferris RL; Ohr JP; Heron DE
    J Radiosurg SBRT; 2019; 6(2):83-89. PubMed ID: 31641545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience.
    Kapitanova I; Biswas S; Divekar S; Kemmerer EJ; Rostock RA; Forster KM; Grimm RJ; Scofield CJ; Grimm J; Emami B; Mahadevan A
    Radiat Oncol; 2021 Jun; 16(1):98. PubMed ID: 34098991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid blowout syndrome in patients with head-and-neck cancers: reconstructive management by self-expandable stent-grafts.
    Chang FC; Lirng JF; Luo CB; Guo WY; Teng MM; Tai SK; Chang CY
    AJNR Am J Neuroradiol; 2007 Jan; 28(1):181-8. PubMed ID: 17213454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.
    Vargo JA; Moiseenko V; Grimm J; Caudell J; Clump DA; Yorke E; Xue J; Vinogradskiy Y; Moros EG; Mavroidis P; Jain S; El Naqa I; Marks LB; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):137-146. PubMed ID: 29477291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.